Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.
The global Opioid Induced Constipation (OIC) Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2022-2027.
The global Opioid Induced Constipation (OIC) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Opioid Induced Constipation (OIC) Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Opioid Induced Constipation (OIC) Drug market are
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Opioid Induced Constipation (OIC) Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Opioid Induced Constipation (OIC) Drug market.
• The market share of the global Opioid Induced Constipation (OIC) Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Opioid Induced Constipation (OIC) Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Opioid Induced Constipation (OIC) Drug market.
The global Opioid Induced Constipation (OIC) Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2022-2027.
The global Opioid Induced Constipation (OIC) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Geographical Analysis:
Based on region, the global Opioid Induced Constipation (OIC) Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Opioid Induced Constipation (OIC) Drug market are
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Opioid Induced Constipation (OIC) Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Opioid Induced Constipation (OIC) Drug market.
• The market share of the global Opioid Induced Constipation (OIC) Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Opioid Induced Constipation (OIC) Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Opioid Induced Constipation (OIC) Drug market.
1 Opioid Induced Constipation (OIC) Drug Market Overview
1.1 Opioid Induced Constipation (OIC) Drug Product Scope
1.2 Opioid Induced Constipation (OIC) Drug Segment by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Opioid Induced Constipation (OIC) Drug Segment by Application
1.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioid Induced Constipation (OIC) Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioid Induced Constipation (OIC) Drug Price Trends (2016-2027)
2 Opioid Induced Constipation (OIC) Drug Estimates and Forecasts by Region
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2016-2021)
2.3 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.2 Europe Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.3 China Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.4 Japan Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.6 India Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
3 Global Opioid Induced Constipation (OIC) Drug Competition Landscape by Players
3.1 Global Top Opioid Induced Constipation (OIC) Drug Players by Sales (2016-2021)
3.2 Global Top Opioid Induced Constipation (OIC) Drug Players by Revenue (2016-2021)
3.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2020)
3.4 Global Opioid Induced Constipation (OIC) Drug Average Price by Company (2016-2021)
3.5 Manufacturers Opioid Induced Constipation (OIC) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioid Induced Constipation (OIC) Drug Market Size by Type
4.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2021)
4.2 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2022-2027)
5 Global Opioid Induced Constipation (OIC) Drug Market Size by Application
5.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioid Induced Constipation (OIC) Drug Price by Application (2016-2021)
5.2 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Application (2022-2027)
6 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures
6.1 North America Opioid Induced Constipation (OIC) Drug Sales by Company
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
6.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
6.2.1 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
6.3 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
6.3.1 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2022-2027)
7 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures
7.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Company
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
7.2.1 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Opioid Induced Constipation (OIC) Drug Market Facts & Figures
8.1 China Opioid Induced Constipation (OIC) Drug Sales by Company
8.1.1 China Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
8.1.2 China Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
8.2 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
8.2.1 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
8.3 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)
9 Japan Opioid Induced Constipation (OIC) Drug Market Facts & Figures
9.1 Japan Opioid Induced Constipation (OIC) Drug Sales by Company
9.1.1 Japan Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
9.1.2 Japan Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
9.2 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
9.2.1 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Facts & Figures
10.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales by Company
10.1.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
10.2.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Opioid Induced Constipation (OIC) Drug Market Facts & Figures
11.1 India Opioid Induced Constipation (OIC) Drug Sales by Company
11.1.1 India Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
11.1.2 India Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
11.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
11.2.1 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
11.3 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
11.3.1 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drug Business
12.1 Ironwood Pharmaceuticals
12.1.1 Ironwood Pharmaceuticals Corporation Information
12.1.2 Ironwood Pharmaceuticals Business Overview
12.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.1.5 Ironwood Pharmaceuticals Recent Development
12.2 Daiichi Sankyo Co
12.2.1 Daiichi Sankyo Co Corporation Information
12.2.2 Daiichi Sankyo Co Business Overview
12.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
12.2.5 Daiichi Sankyo Co Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
12.3.5 Pfizer Recent Development
12.4 Progenics Pharmaceuticals
12.4.1 Progenics Pharmaceuticals Corporation Information
12.4.2 Progenics Pharmaceuticals Business Overview
12.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.4.5 Progenics Pharmaceuticals Recent Development
12.5 Shionogi &
12.5.1 Shionogi & Corporation Information
12.5.2 Shionogi & Business Overview
12.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
12.5.5 Shionogi & Recent Development
12.6 Allergan
12.6.1 Allergan Corporation Information
12.6.2 Allergan Business Overview
12.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
12.6.5 Allergan Recent Development
12.7 Nektar Therapeutics
12.7.1 Nektar Therapeutics Corporation Information
12.7.2 Nektar Therapeutics Business Overview
12.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
12.7.5 Nektar Therapeutics Recent Development
12.8 Purdue Pharma
12.8.1 Purdue Pharma Corporation Information
12.8.2 Purdue Pharma Business Overview
12.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
12.8.5 Purdue Pharma Recent Development
12.9 S.L.A. Pharma
12.9.1 S.L.A. Pharma Corporation Information
12.9.2 S.L.A. Pharma Business Overview
12.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
12.9.5 S.L.A. Pharma Recent Development
12.10 Mundipharma International Limited
12.10.1 Mundipharma International Limited Corporation Information
12.10.2 Mundipharma International Limited Business Overview
12.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
12.10.5 Mundipharma International Limited Recent Development
12.11 Ono Pharmaceutical
12.11.1 Ono Pharmaceutical Corporation Information
12.11.2 Ono Pharmaceutical Business Overview
12.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Products Offered
12.11.5 Ono Pharmaceutical Recent Development
12.12 Takeda Pharmaceutical Company Limited
12.12.1 Takeda Pharmaceutical Company Limited Corporation Information
12.12.2 Takeda Pharmaceutical Company Limited Business Overview
12.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Products Offered
12.12.5 Takeda Pharmaceutical Company Limited Recent Development
12.13 Theravance Biopharma
12.13.1 Theravance Biopharma Corporation Information
12.13.2 Theravance Biopharma Business Overview
12.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Products Offered
12.13.5 Theravance Biopharma Recent Development
12.14 Bausch Health
12.14.1 Bausch Health Corporation Information
12.14.2 Bausch Health Business Overview
12.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Products Offered
12.14.5 Bausch Health Recent Development
12.15 Cosmo Pharmaceuticals SA
12.15.1 Cosmo Pharmaceuticals SA Corporation Information
12.15.2 Cosmo Pharmaceuticals SA Business Overview
12.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Products Offered
12.15.5 Cosmo Pharmaceuticals SA Recent Development
12.16 Daewoong Pharmaceutical
12.16.1 Daewoong Pharmaceutical Corporation Information
12.16.2 Daewoong Pharmaceutical Business Overview
12.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Products Offered
12.16.5 Daewoong Pharmaceutical Recent Development
12.17 C.B. Fleet Company
12.17.1 C.B. Fleet Company Corporation Information
12.17.2 C.B. Fleet Company Business Overview
12.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Products Offered
12.17.5 C.B. Fleet Company Recent Development
12.18 Sucampo Pharmaceuticals
12.18.1 Sucampo Pharmaceuticals Corporation Information
12.18.2 Sucampo Pharmaceuticals Business Overview
12.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.18.5 Sucampo Pharmaceuticals Recent Development
13 Opioid Induced Constipation (OIC) Drug Manufacturing Cost Analysis
13.1 Opioid Induced Constipation (OIC) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
13.4 Opioid Induced Constipation (OIC) Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioid Induced Constipation (OIC) Drug Distributors List
14.3 Opioid Induced Constipation (OIC) Drug Customers
15 Market Dynamics
15.1 Opioid Induced Constipation (OIC) Drug Market Trends
15.2 Opioid Induced Constipation (OIC) Drug Drivers
15.3 Opioid Induced Constipation (OIC) Drug Market Challenges
15.4 Opioid Induced Constipation (OIC) Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
1.1 Opioid Induced Constipation (OIC) Drug Product Scope
1.2 Opioid Induced Constipation (OIC) Drug Segment by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Opioid Induced Constipation (OIC) Drug Segment by Application
1.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Opioid Induced Constipation (OIC) Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Opioid Induced Constipation (OIC) Drug Price Trends (2016-2027)
2 Opioid Induced Constipation (OIC) Drug Estimates and Forecasts by Region
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2016-2021)
2.3 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.2 Europe Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.3 China Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.4 Japan Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
2.4.6 India Opioid Induced Constipation (OIC) Drug Estimates and Projections (2016-2027)
3 Global Opioid Induced Constipation (OIC) Drug Competition Landscape by Players
3.1 Global Top Opioid Induced Constipation (OIC) Drug Players by Sales (2016-2021)
3.2 Global Top Opioid Induced Constipation (OIC) Drug Players by Revenue (2016-2021)
3.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2020)
3.4 Global Opioid Induced Constipation (OIC) Drug Average Price by Company (2016-2021)
3.5 Manufacturers Opioid Induced Constipation (OIC) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioid Induced Constipation (OIC) Drug Market Size by Type
4.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2021)
4.2 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2022-2027)
5 Global Opioid Induced Constipation (OIC) Drug Market Size by Application
5.1 Global Opioid Induced Constipation (OIC) Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Opioid Induced Constipation (OIC) Drug Price by Application (2016-2021)
5.2 Global Opioid Induced Constipation (OIC) Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Application (2022-2027)
6 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures
6.1 North America Opioid Induced Constipation (OIC) Drug Sales by Company
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
6.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
6.2.1 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
6.3 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
6.3.1 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2022-2027)
7 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures
7.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Company
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
7.2.1 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Opioid Induced Constipation (OIC) Drug Market Facts & Figures
8.1 China Opioid Induced Constipation (OIC) Drug Sales by Company
8.1.1 China Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
8.1.2 China Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
8.2 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
8.2.1 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
8.3 China Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)
9 Japan Opioid Induced Constipation (OIC) Drug Market Facts & Figures
9.1 Japan Opioid Induced Constipation (OIC) Drug Sales by Company
9.1.1 Japan Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
9.1.2 Japan Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
9.2 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
9.2.1 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Opioid Induced Constipation (OIC) Drug Market Facts & Figures
10.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales by Company
10.1.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
10.2.1 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Opioid Induced Constipation (OIC) Drug Market Facts & Figures
11.1 India Opioid Induced Constipation (OIC) Drug Sales by Company
11.1.1 India Opioid Induced Constipation (OIC) Drug Sales by Company (2016-2021)
11.1.2 India Opioid Induced Constipation (OIC) Drug Revenue by Company (2016-2021)
11.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type
11.2.1 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Type (2022-2027)
11.3 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application
11.3.1 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Opioid Induced Constipation (OIC) Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drug Business
12.1 Ironwood Pharmaceuticals
12.1.1 Ironwood Pharmaceuticals Corporation Information
12.1.2 Ironwood Pharmaceuticals Business Overview
12.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.1.5 Ironwood Pharmaceuticals Recent Development
12.2 Daiichi Sankyo Co
12.2.1 Daiichi Sankyo Co Corporation Information
12.2.2 Daiichi Sankyo Co Business Overview
12.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
12.2.5 Daiichi Sankyo Co Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
12.3.5 Pfizer Recent Development
12.4 Progenics Pharmaceuticals
12.4.1 Progenics Pharmaceuticals Corporation Information
12.4.2 Progenics Pharmaceuticals Business Overview
12.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.4.5 Progenics Pharmaceuticals Recent Development
12.5 Shionogi &
12.5.1 Shionogi & Corporation Information
12.5.2 Shionogi & Business Overview
12.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
12.5.5 Shionogi & Recent Development
12.6 Allergan
12.6.1 Allergan Corporation Information
12.6.2 Allergan Business Overview
12.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
12.6.5 Allergan Recent Development
12.7 Nektar Therapeutics
12.7.1 Nektar Therapeutics Corporation Information
12.7.2 Nektar Therapeutics Business Overview
12.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
12.7.5 Nektar Therapeutics Recent Development
12.8 Purdue Pharma
12.8.1 Purdue Pharma Corporation Information
12.8.2 Purdue Pharma Business Overview
12.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
12.8.5 Purdue Pharma Recent Development
12.9 S.L.A. Pharma
12.9.1 S.L.A. Pharma Corporation Information
12.9.2 S.L.A. Pharma Business Overview
12.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
12.9.5 S.L.A. Pharma Recent Development
12.10 Mundipharma International Limited
12.10.1 Mundipharma International Limited Corporation Information
12.10.2 Mundipharma International Limited Business Overview
12.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
12.10.5 Mundipharma International Limited Recent Development
12.11 Ono Pharmaceutical
12.11.1 Ono Pharmaceutical Corporation Information
12.11.2 Ono Pharmaceutical Business Overview
12.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Products Offered
12.11.5 Ono Pharmaceutical Recent Development
12.12 Takeda Pharmaceutical Company Limited
12.12.1 Takeda Pharmaceutical Company Limited Corporation Information
12.12.2 Takeda Pharmaceutical Company Limited Business Overview
12.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Products Offered
12.12.5 Takeda Pharmaceutical Company Limited Recent Development
12.13 Theravance Biopharma
12.13.1 Theravance Biopharma Corporation Information
12.13.2 Theravance Biopharma Business Overview
12.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Products Offered
12.13.5 Theravance Biopharma Recent Development
12.14 Bausch Health
12.14.1 Bausch Health Corporation Information
12.14.2 Bausch Health Business Overview
12.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Products Offered
12.14.5 Bausch Health Recent Development
12.15 Cosmo Pharmaceuticals SA
12.15.1 Cosmo Pharmaceuticals SA Corporation Information
12.15.2 Cosmo Pharmaceuticals SA Business Overview
12.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Products Offered
12.15.5 Cosmo Pharmaceuticals SA Recent Development
12.16 Daewoong Pharmaceutical
12.16.1 Daewoong Pharmaceutical Corporation Information
12.16.2 Daewoong Pharmaceutical Business Overview
12.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Products Offered
12.16.5 Daewoong Pharmaceutical Recent Development
12.17 C.B. Fleet Company
12.17.1 C.B. Fleet Company Corporation Information
12.17.2 C.B. Fleet Company Business Overview
12.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Products Offered
12.17.5 C.B. Fleet Company Recent Development
12.18 Sucampo Pharmaceuticals
12.18.1 Sucampo Pharmaceuticals Corporation Information
12.18.2 Sucampo Pharmaceuticals Business Overview
12.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
12.18.5 Sucampo Pharmaceuticals Recent Development
13 Opioid Induced Constipation (OIC) Drug Manufacturing Cost Analysis
13.1 Opioid Induced Constipation (OIC) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
13.4 Opioid Induced Constipation (OIC) Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioid Induced Constipation (OIC) Drug Distributors List
14.3 Opioid Induced Constipation (OIC) Drug Customers
15 Market Dynamics
15.1 Opioid Induced Constipation (OIC) Drug Market Trends
15.2 Opioid Induced Constipation (OIC) Drug Drivers
15.3 Opioid Induced Constipation (OIC) Drug Market Challenges
15.4 Opioid Induced Constipation (OIC) Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
